Heather Wasserman is the founder of Remix Therapeutics. Remix Therapeutics has raised $211M in total funding. Latest round: Growth.
Heather Wasserman is the Chief Operating Officer and Chief Business Officer (COO/CBO) at Remix Therapeutics, a biotechnology company focused on developing small molecule therapies. She has held this role since the company's founding in August 2020. She is not listed as a founder or CEO.
Full founder directory · Investor directory · Company funding database · Fundraising library